Skip to main content Skip to section navigation Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • ESG
    • Documents and Policies
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Sep 20, 2023 4:05pm EDT

Societal CDMO Announces Corporate Restructuring

Sep 07, 2023 7:00am EDT

Societal CDMO Secures Project Expansion Agreements With Several Existing Customers

Aug 29, 2023 7:00am EDT

Societal CDMO Announces Closing of $8.3 Million Public Offering of Common Stock

Aug 24, 2023 7:30am EDT

Societal CDMO Announces Pricing of $8.3 Million Public Offering of Common Stock

Aug 23, 2023 4:04pm EDT

Societal CDMO Announces Appointment of Matt Arens to Board of Directors

Aug 23, 2023 4:04pm EDT

Societal CDMO Announces Proposed Public Offering of Common Stock

Aug 14, 2023 4:05pm EDT

Societal CDMO Reports Second Quarter 2023 Financial Results

Aug 09, 2023 7:00am EDT

Societal CDMO Reschedules Second Quarter 2023 Financial Results Reporting to August 14, 2023

Aug 02, 2023 4:05pm EDT

Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023

Jul 26, 2023 7:00am EDT

Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us